Current outlook on molecular pathogenesis and treatment of myeloproliferative neoplasms.

Tibes, Raoul

Current outlook on molecular pathogenesis and treatment of myeloproliferative neoplasms. [electronic resource] - Molecular diagnosis & therapy Oct 2012 - 269-83 p. digital

Publication Type: Journal Article; Review

1179-2000

10.1007/s40291-012-0006-3 doi


Adaptor Proteins, Signal Transducing
Alleles
Benzamides--therapeutic use
Bridged-Ring Compounds--therapeutic use
Carbazoles--therapeutic use
Chromatin--genetics
DNA (Cytosine-5-)-Methyltransferases--genetics
DNA Methyltransferase 3A
DNA-Binding Proteins--genetics
Dioxygenases
Enhancer of Zeste Homolog 2 Protein
Epigenesis, Genetic
Furans
Gene Expression Regulation
Humans
Ikaros Transcription Factor--genetics
Intracellular Signaling Peptides and Proteins
Isocitrate Dehydrogenase--genetics
Janus Kinase 2--antagonists & inhibitors
Mutation
Myeloproliferative Disorders--genetics
Nitriles
Polycomb Repressive Complex 2--genetics
Proteins--genetics
Proto-Oncogene Proteins--genetics
Proto-Oncogene Proteins c-cbl--genetics
Pyrazoles--therapeutic use
Pyrimidines--therapeutic use
Pyrrolidines--therapeutic use
Receptors, Thrombopoietin--genetics
Repressor Proteins--genetics
Signal Transduction
Spliceosomes--metabolism
Sulfonamides--therapeutic use